Join Proscia and leaders from the life sciences research community as they share their vision for data-driven R&D and how a modern approach to digital pathology is enabling their teams to unlock new insights from their existing data. The roundtable will conclude with a look at the Summer 2020 release of Proscia’s Concentriq for Research.
Proscia's Digital Transformation Officer Dr. Monica Santamaria-Fries will present an on-demand session, "Hanging Up Our Microscopes: Improving The Pathologist Experience With Digital Solutions," and host a live QA on Wednesday, October 28th at 3:50PM PT.
Tate York Director of Digital Microscopy and Image Analysis, NeuroScience Associates
Ashley Murgatroyd Director of Product, Proscia
Digital pathology is opening up new opportunities for CROs to deliver value to their clients. Yet, without the right digital pathology solution in place, a CRO – and the researchers it works with – will struggle to realize these benefits. Hear how NSA Labs is strengthening the researcher-CRO relationship with Concentriq.
Dr. Anthony Magliocco President and CEO, Protean BioDiagnostics
The verdict is in: Labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains. During this webinar, industry experts and pathologists will share their lessons learned and best practices on the meaningful adoption and scale up of digital and computational pathology.
Explore how integrating Visiopharm’s VIS image analysis (IA) suite into Proscia’s Concentriq image management platform creates a connected digital ecosystem that facilitates the introduction of analysis results into routine research.
Join us as we explore the most comprehensive pathology AI validation study conducted to date, including how we address sources of variability seen in practice to achieve an overall 98% classification accuracy across laboratory settings.
We're excited to show you the future of pathology at USCAP 2020. If you'll be at the event in Los Angeles, be sure to stop by our booth (#328) or schedule a meeting to see our Concentriq digital pathology platform in action.
Our team will be in London for the 6th Annual Digital Pathology and AI Congress. With a theme of utilizing AI and digital pathology to advance pathology practice and enable enhanced patient care, this event promises great presentations and networking opportunities.
Chief Product Officer Nathan Buchbinder is heading to Denver to join leaders from Dell EMC, NVIDIA, and WWT at this event focused on emerging healthcare trends and solutions. He'll speak to the promise of AI-powered digital pathology and the work that Proscia is doing to improve cancer research and diagnosis.